These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8676821)

  • 1. Effect of plasma oncotic pressure on apolipoprotein levels in rats with Heymann nephritis.
    Kaysen GA; Jones H; Joles JA; van Tol A
    Miner Electrolyte Metab; 1996; 22(1-3):31-8. PubMed ID: 8676821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein gene expression in analbuminemic rats and in rats with Heymann nephritis.
    Sun X; Jones H; Joles JA; van Tol A; Kaysen GA
    Am J Physiol; 1992 May; 262(5 Pt 2):F755-61. PubMed ID: 1590420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oncotic pressure on apolipoprotein A-I metabolism in the rat.
    Kaysen GA; Hoye E; Jones H; van Tol A; Joles JA
    Am J Kidney Dis; 1995 Jul; 26(1):178-86. PubMed ID: 7611250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial chylomicron binding is altered by interaction with high-density lipoprotein in Heymann's nephritis.
    Shearer GC; Couser WG; Kaysen GA
    Am J Kidney Dis; 2001 Dec; 38(6):1385-9. PubMed ID: 11728980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis.
    Kaysen GA
    Miner Electrolyte Metab; 1992; 18(2-5):212-6. PubMed ID: 1465061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein AI levels are increased in part as a consequence of reduced catabolism in nephrotic rats.
    Kaysen GA; Hoye E; Jones H
    Am J Physiol; 1995 Mar; 268(3 Pt 2):F532-40. PubMed ID: 7900854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
    Joven J; Vilella E
    Clin Nephrol; 1997 Sep; 48(3):141-5. PubMed ID: 9342484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal changes of plasma apo AI and apo E levels in streptozotocin-induced diabetic rats.
    Yamada N; Murase T; Iwamoto Y; Mashiko S; Akanuma Y
    Horm Metab Res; 1984 Dec; 16 Suppl 1():85-8. PubMed ID: 6442708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal apolipoproteins in nephrotic rats.
    van Goor H; van der Horst ML; Atmosoerodjo J; Joles JA; van Tol A; Grond J
    Am J Pathol; 1993 Jun; 142(6):1804-12. PubMed ID: 8506949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered hepatic production of apolipoproteins B and E in the fasted septic rat: factors in the development of hypertriglyceridemia.
    Tripp RJ; Tabares A; Wang H; Lanza-Jacoby S
    J Surg Res; 1993 Nov; 55(5):465-72. PubMed ID: 8231164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of adrenocorticotrophic hormone and an equivalent dose of cortisol on the serum concentrations of lipids, lipoproteins, and apolipoproteins.
    Berg AL; Rafnsson AT; Johannsson M; Dallongeville J; Arnadottir M
    Metabolism; 2006 Aug; 55(8):1083-7. PubMed ID: 16839845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoproteins and renal apolipoproteins in rats with chronic adriamycin nephrosis.
    Joles JA; van Tol A; Jansen EH; Koomans HA; Rabelink TJ; Grond J; van Goor H
    Nephrol Dial Transplant; 1993; 8(9):831-8. PubMed ID: 8255516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dietary protein intake and angiotensin converting enzyme inhibition in Heymann nephritis.
    Kaysen GA; Davies RW; Hutchison FN
    Kidney Int Suppl; 1989 Nov; 27():S154-62. PubMed ID: 2561514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinate augmentation in expression of genes encoding transcription factors and liver secretory proteins in hypo-oncotic states.
    Kang J; Holland M; Jones H; Kaysen GA
    Kidney Int; 1999 Aug; 56(2):452-60. PubMed ID: 10432383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of weight loss on plasma apolipoproteins in postmenopausal women.
    Fernandez ML; Metghalchi S; Vega-López S; Conde-Knape K; Lohman TG; Cordero-Macintyre ZR
    J Nutr Biochem; 2004 Dec; 15(12):717-21. PubMed ID: 15607644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein B gene variants are involved in the determination of blood glucose and lipid levels in patients with non-insulin dependent diabetes mellitus.
    Duman BS; Oztürk M; Yilmazer S; Cağatay P; Hatemi H
    Cell Biochem Funct; 2006; 24(3):261-7. PubMed ID: 16634094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
    de Sain-van der Velden MG; Kaysen GA; Barrett HA; Stellaard F; Gadellaa MM; Voorbij HA; Reijngoud DJ; Rabelink TJ
    Kidney Int; 1998 Apr; 53(4):994-1001. PubMed ID: 9551409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.